Scientists at the University of Cambridge have created a test that could predict if a cancer patient is sensitive or ...

Combining anthracycline and taxane for early-stage operable breast cancer was more effective than either anthracycline or taxane chemotherapy alone in reducing breast cancer recurrence and death ...

In September 2007, the FDA approved dexrazoxane hydrochloride injection for the treatment of extravasation resulting from intravenous anthracycline chemotherapy. Dexrazoxane (Zinecard, Pfizer) has ...

Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer ...

Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ( ...

Anthracyclines are antibiotics that can help treat breast cancer. Learn more about how they work, how effective they are, and if there are side effects.

Oncologists vary widely in treating DLBCL with cardiomyopathy, often diverging from guidelines due to limited evidence on ...

The benefit of anthracycline therapy was also found to increase as the RS increased above 31, while no trend toward benefit was seen in patients with a score between 26 and 30.

However, anthracycline-associated cardiotoxicity requires careful assessment in some cases. The risk of anthracycline-associated cardiac events is dose dependent.

The most common types of cancer were lymphoma (40.2%) and breast cancer (32.4%), 36.1% had metastatic disease, 93.5% received doxorubicin, and the average cumulative anthracycline dose was 198.1± ...